MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejca.2022.11.008

Медицинская библиотека · European journal of cancer (Oxford, England : 1990) · 2022

Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022.

Rothermundt Christian, Andreou Dimosthenis, Blay Jean-Yves, Brodowicz Thomas, Desar Ingrid M E, Dileo Palma, Gelderblom Hans, Haas Rick, Jakob Jens, Jones Robin L, Judson Ian, Kunz Wolfgang G, Liegl-Atzwanger Berndadette, Lindner Lars H, Messiou Christina, Miah Aisha B, Reichardt Peter, Szkandera Joanna, van der Graaf Winette T A, van Houdt Winan J, Wardelmann Eva, Hofer Silvia, Writing committee on behalf of CSSS panellists

СтатьяConsensus StatementПеревод пока не подготовлен

Аннотация

BACKGROUND

Owing to the rarity and heterogeneity in biology and presentation, there are multiple areas in the diagnosis, treatment and follow-up of soft tissue sarcoma (STS), with no, low-level or conflicting evidence.

METHODS

During the first Consensus Conference on the State of Science in Sarcoma (CSSS), we used a modified Delphi process to identify areas of controversy in the field of sarcoma, to name topics with limited evidence-based data in which a scientific and knowledge gap may remain and a consensus statement will help to guide patient management. We determined scientific questions which need to be addressed in the future in order to generate evidence and to inform physicians and caregivers in daily clinical practice in order to improve the outcomes of patients with sarcoma. We conducted a vote on STS key questions and controversies prior to the CSSS meeting, which took place in May 2022.

RESULTS

Sixty-two European sarcoma experts participated in the survey. Sixteen strong consensus (≥95%) items were identified by the experts, as well as 30 items with a ≥75% consensus on diagnostic and therapeutic questions. Ultimately, many controversy topics remained without consensus.

CONCLUSIONS

In this manuscript, we summarise the voting results and the discussion during the CSSS meeting. Future scientific questions, priorities for clinical trials, registries, quality assurance, and action by stakeholders are proposed. Platforms and partnerships can support innovative approaches to improve management and clinical research in STS.

Для цитирования: Rothermundt Christian, Andreou Dimosthenis, Blay Jean-Yves, Brodowicz Thomas, Desar Ingrid M E, Dileo Palma, Gelderblom Hans, Haas Rick, Jakob Jens, Jones Robin L, Judson Ian, Kunz Wolfgang G, Liegl-Atzwanger Berndadette, Lindner Lars H, Messiou Christina, Miah Aisha B, Reichardt Peter, Szkandera Joanna, van der Graaf Winette T A, van Houdt Winan J, Wardelmann Eva, Hofer Silvia, Writing committee on behalf of CSSS panellists. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022.. European journal of cancer (Oxford, England : 1990). 2022. DOI: 10.1016/j.ejca.2022.11.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.